Find what you are looking for

Retatrutide vs Tirzepatide

Retatrutide vs Tirzepatide: the material compared side by side — what each compound acts on, how it is supplied, its documented purity and the batch certificate of analysis (CoA). Every compound is supplied strictly for research and analytical purposes.

Retatrutide vs Tirzepatide

Retatrutide 32
Retatrutide 32 research peptide pen
Research area
Weight-loss and metabolism research
Receptor target
Triple agonist: GLP-1, GIP and glucagon receptors
Presentation
Pre-filled multi-dose pen · 2/4/8 mg setting
Strength
32 mg
HPLC purity
98.75%
Studied alongside
Tirzepatide
249 €
Tirzepatide 60
Tirzepatide 60 research peptide pen
Research area
Weight-loss and metabolism research
Receptor target
Dual agonist: GLP-1 and GIP receptors
Presentation
Pre-filled multi-dose pen
Strength
60 mg
HPLC purity
99.27%
Studied alongside
Retatrutide
199 €

Supplied strictly for research and analytical purposes. Not for human consumption and not medical advice. The data above describe the material as delivered; purity comes from the published certificate of analysis (CoA) of the current batch.

Retatrutide vs Tirzepatide: the comparison

Retatrutide vs Tirzepatide: the material compared side by side — what each compound acts on, how it is supplied, its documented purity and the batch certificate of analysis (CoA). Every compound is supplied strictly for research and analytical purposes. The table above shows, for each compound, the receptor target and mechanism, the format, the documented HPLC purity of the current batch and a link to the published certificate of analysis (CoA). Prices are shown in euros and are updated from the current catalogue.

These data describe the material as delivered. Body Pharm publishes no human dosing protocols and no efficacy claims: every compound is strictly for research and analytical use, and not for human consumption.

Supplier comparisons

Body Pharm against other suppliers

Data-based comparisons between the Body Pharm catalogue and other research peptide suppliers in Spain and Europe: format, amount of active compound, price per milligram, certificate of analysis and delivery, side by side. Research use only.

Body Pharm Retatrutida 64 mg en pluma vs. Retatrutida 20 mg vial de Peptalia: comparativa
Retatrutida · Body Pharm vs Peptalia
Body Pharm Retatrutida 32 mg en pluma vs. Retatrutida 20 mg vial de Peptalia: comparativa
Retatrutida · Body Pharm vs Peptalia
Body Pharm Retatrutida 32 mg en pluma vs. Retatrutide 5 mg, pluma premezclada de ORYN Peptide Labs: comparativa
Retatrutida · Body Pharm vs ORYN Peptide Labs
Body Pharm Tirzepatida 60 mg en pluma vs. Tirzemax (Tirzepatida) 30 mg vial de Peptalia: comparativa
Tirzepatida · Body Pharm vs Peptalia
Body Pharm BPC-157 + TB-500 32 mg en pluma vs. Wolverine Blend BPC-157 10 mg + TB-500 10 mg de Pepspan: comparativa
BPC-157 + TB-500 · Body Pharm vs Pepspan
Body Pharm BPC-157 + TB-500 32 mg en pluma vs. TB-500 + BPC-157, vial combinado de 10 mg de Peptalia: comparativa
BPC-157 + TB-500 · Body Pharm vs Peptalia
Body Pharm CJC-1295 + ipamorelina 20 mg en pluma vs. CJC-1295 5 mg en pluma + ipamorelina 6 mg en pluma de ORYN Peptide Labs: comparativa
CJC-1295 + ipamorelina · Body Pharm vs ORYN Peptide Labs
Body Pharm CJC-1295 + ipamorelina 20 mg en pluma vs. CJC-1295 + ipamorelina, vial combinado de 5 mg + 5 mg de Pepspan: comparativa
CJC-1295 + ipamorelina · Body Pharm vs Pepspan
Body Pharm Tesamorelina 32 mg en pluma vs. Tesamorelina 10 mg vial de Peptalia: comparativa
Tesamorelina · Body Pharm vs Peptalia
Body Pharm Melanotán II 20 mg en pluma vs. Melanotan 2 10 mg vial (impuestos incluidos) de Particle Peptides: comparativa
Melanotán II · Body Pharm vs Particle Peptides
Body Pharm NAD+ 1000 mg en pluma vs. NAD+ 1000 mg vial de Peptalia: comparativa
NAD+ · Body Pharm vs Peptalia
Body Pharm MOTS-c 32 mg en pluma vs. MOTS-c 10 mg vial de Pepspan: comparativa
MOTS-c · Body Pharm vs Pepspan